Maxzar-NT Tablet SR is a sustained-release formulation combining Pregabalin 75mg, Nortriptyline 10mg, and Methylcobalamin 1500mcg, designed for the management of neuropathic pain and related conditions. Pregabalin, an anticonvulsant and analgesic agent, modulates calcium channel function to reduce neurotransmitter release, thereby alleviating neuropathic pain and improving nerve function. Nortriptyline, a tricyclic antidepressant, enhances noradrenergic and serotonergic neurotransmission, contributing to analgesic effects and mood stabilization in chronic pain syndromes. Methylcobalamin, an active form of vitamin B12, supports nerve regeneration and repair, promoting functional recovery in peripheral neuropathies. The sustained-release mechanism ensures prolonged therapeutic plasma concentrations, improving patient compliance and minimizing peak-related side effects. Maxzar-NT is indicated for diabetic neuropathy, postherpetic neuralgia, and other neuropathic pain disorders where multimodal therapy is beneficial. It should be used under medical supervision, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include dizziness, dry mouth, somnolence, and gastrointestinal disturbances. Caution is advised in patients with renal impairment, cardiovascular disease, or concomitant CNS depressants. Maxzar-NT Tablet SR offers a comprehensive approach to neuropathic pain management by combining analgesic, antidepressant, and neurotrophic agents in a single, convenient dosage form.